Menu
GeneBe

rs148157138

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_005249.5(FOXG1):c.503G>C(p.Gly168Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000798 in 1,603,636 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G168V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

FOXG1
NM_005249.5 missense

Scores

2
1
16

Clinical Significance

Benign reviewed by expert panel B:7

Conservation

PhyloP100: 3.88
Variant links:
Genes affected
FOXG1 (HGNC:3811): (forkhead box G1) This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
LINC01551 (HGNC:19828): (long intergenic non-protein coding RNA 1551)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant where missense usually causes diseases, FOXG1
BP4
Computational evidence support a benign effect (MetaRNN=0.014331877).
BP6
Variant 14-28767782-G-C is Benign according to our data. Variant chr14-28767782-G-C is described in ClinVar as [Benign]. Clinvar id is 205474.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr14-28767782-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.000434 (66/152064) while in subpopulation AFR AF= 0.00154 (64/41534). AF 95% confidence interval is 0.00124. There are 0 homozygotes in gnomad4. There are 31 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd at 66 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FOXG1NM_005249.5 linkuse as main transcriptc.503G>C p.Gly168Ala missense_variant 1/1 ENST00000313071.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FOXG1ENST00000313071.7 linkuse as main transcriptc.503G>C p.Gly168Ala missense_variant 1/1 NM_005249.5 P1
FOXG1ENST00000706482.1 linkuse as main transcriptc.503G>C p.Gly168Ala missense_variant 2/2 P1
LINC01551ENST00000675861.1 linkuse as main transcriptn.374+1769G>C intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.000434
AC:
66
AN:
151954
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00155
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000128
AC:
30
AN:
234708
Hom.:
0
AF XY:
0.0000933
AC XY:
12
AN XY:
128668
show subpopulations
Gnomad AFR exome
AF:
0.00179
Gnomad AMR exome
AF:
0.0000884
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000171
GnomAD4 exome
AF:
0.0000427
AC:
62
AN:
1451572
Hom.:
0
Cov.:
35
AF XY:
0.0000332
AC XY:
24
AN XY:
721954
show subpopulations
Gnomad4 AFR exome
AF:
0.00165
Gnomad4 AMR exome
AF:
0.0000900
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000498
GnomAD4 genome
AF:
0.000434
AC:
66
AN:
152064
Hom.:
0
Cov.:
32
AF XY:
0.000417
AC XY:
31
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.00154
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.000525
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000149
AC:
18

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2022FOXG1: PP2, BS1 -
Benign, criteria provided, single submitterclinical testingGeneDxOct 25, 2019- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 23, 2017- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 25, 2019This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
FOXG1 disorder Benign:1
Benign, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelMar 26, 2021The allele frequency of the p.Gly168Ala variant in FOXG1 is 0.18% in African sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). Computational analysis prediction tools suggest that the p.Gly168Ala variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Gly168Ala variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP4). -
FOXG1-related disorder Benign:1
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJun 01, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Rett syndrome, congenital variant Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 22, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.020
T
BayesDel_noAF
Benign
-0.27
Cadd
Uncertain
24
Dann
Benign
0.97
DEOGEN2
Benign
0.37
T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.44
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.71
T
M_CAP
Pathogenic
0.67
D
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-0.48
T
MutationAssessor
Benign
0.55
N
MutationTaster
Benign
0.53
D;D
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.96
N
REVEL
Benign
0.21
Sift
Benign
0.051
T
Sift4G
Benign
0.37
T
Polyphen
0.0010
B
Vest4
0.10
MVP
0.32
ClinPred
0.021
T
GERP RS
0.91
Varity_R
0.096
gMVP
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148157138; hg19: chr14-29236988; API